Table 1 Prevalence of NCAH due to 21-hydroxylase deficiency among hyperandrogenic women.
Country | Total # of Women | # NCAH (%) | Citation |
|---|---|---|---|
USA (NE) | 22* | 2 (9%) | Emans et al., 1983 [8] |
USA (NE) | 139 | 2 (1.4%) | Cobin et al., 1985 [9] |
USA (NE) | 164 | 4 (2.4%) | Azziz and Zacur, 1989 [10] |
USA (SE) | 86 | 2 (2.3%) | Azziz et al., 1993 [11] |
USA (SW) | 83 | 1 (1.2%) | Chetkowski et al., 1984 [12] |
USA (SE) | 873 | 18 (1.6%) | Azziz et al., 2004 [13] |
Canada | 72 | 4 (5.5%) | Innanen and Vale, 1990 [14] |
Puerto Rico | 100 | 1 (1.0%) | Romaguera et al., 2000 [15] |
Ireland | 96 | 6 (6.2%) | McLaughlin et al., 1990 [16] |
England | 50 | 1 (2.0%) | Turner et al., 1992 [17] |
France | 400 | 24 (6.0%) | Kuttenn et al., 1985 [18] |
France | 69 | 16 (23%) | Blanch |
Portugal | 129 | 23 (17.8%) | Pall et al., (in press) [20] |
Italy (South) | 372 | 14 (4.0%) | Carmina et al., 1987 [21] |
Italy (North) | 85 | 1 (1.1%) | Motta et al., 1988 [22] |
Italy (Palermo) | 950 | 41 (4.5%) | Carmina et al., 2006 [23] |
Spain | 270 | 6 (2.2%) | Escobar-Morreale et al., 2008 [24] |
Czech Republic | 298 | 8 (2.7%) | Fanta et al., 2008 [25] |
Greece | 107 | 10 (9.3%) | Trakakis et al., 2008 [26] |
Turkey (Ankara) | 32* | 1(3%) | Akinci et al., 1992 [27] |
Turkey (Istanbul) | 61 | 20 (33%) | Yarman et al., 2004 [28] |
Turkey (Kayseri) | 285 | 6 (2.1%) | Unluhizarci et al., 2010 [29] |
Turkey (Central Anatolia) | 63 | 6 (9.5%) | Kamel et al., 2003 [30] |
Israel | 170 | 14 (8.2%) | Eldar-Geva et al., 1990 [31] |
India | 60 | 3 (8.3%) | Mithal et al., 1988 [32] |
India | 63 | 3 (5.7%) | Khandekar et al., 1990 [33] |
et al., 1997 [